The FDA is shutting down a pain management program that has helped supply fentanyl to cancer patients suffering from severe pain, according to a notice from the agency.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA to shutter fentanyl access program for cancer patients
